Ftse Mib
34.728,68
0,93%
DAX
19.473,63
1,32%
S&P 500
5.738,76
-0,12%
NASDAQ
18.108,98
-0,45%
Bitcoin
65.709,68
0,81%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Creative Medical Technology Holdings Inc (CELZ) Creative Medical Technology Holdings Inc (CELZ) Notizie

CELZ

Creative Medical Technol... (CELZ)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CELZ
DataOraFonteTitoloSimboloCompagnia
09/08/202422:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CELZCreative Medical Technology Holdings Inc
25/07/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELZCreative Medical Technology Holdings Inc
24/07/202415:00GlobeNewswire Inc.Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine ProgramNASDAQ:CELZCreative Medical Technology Holdings Inc
10/07/202414:30GlobeNewswire Inc.Creative Medical Technology Holdings Provides Corporate UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
24/06/202414:30GlobeNewswire Inc.Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human InsulinNASDAQ:CELZCreative Medical Technology Holdings Inc
05/06/202422:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CELZCreative Medical Technology Holdings Inc
17/05/202422:01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CELZCreative Medical Technology Holdings Inc
07/03/202415:15Business WireCreative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded AccessNASDAQ:CELZCreative Medical Technology Holdings Inc
06/03/202422:10AllPennyStocks.comBiotech Finds Mid-Week Success Following FDA AnnouncementNASDAQ:CELZCreative Medical Technology Holdings Inc
06/03/202413:00Business WireCreative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation TherapyNASDAQ:CELZCreative Medical Technology Holdings Inc
10/10/202314:00PR Newswire (US)Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back PainNASDAQ:CELZCreative Medical Technology Holdings Inc
19/09/202314:00PR Newswire (US)Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back PainNASDAQ:CELZCreative Medical Technology Holdings Inc
29/06/202323:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELZCreative Medical Technology Holdings Inc
29/06/202323:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELZCreative Medical Technology Holdings Inc
28/06/202315:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
28/06/202314:00PR Newswire (US)Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing RequirementsNASDAQ:CELZCreative Medical Technology Holdings Inc
12/06/202314:01PR Newswire (US)Creative Medical Technology Announces $2 Million Share Repurchase ProgramNASDAQ:CELZCreative Medical Technology Holdings Inc
09/06/202318:30PR Newswire (US)Creative Medical Technology Holdings Announces Reverse Stock SplitNASDAQ:CELZCreative Medical Technology Holdings Inc
31/05/202314:00PR Newswire (US)Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy PlatformNASDAQ:CELZCreative Medical Technology Holdings Inc
22/05/202314:30PR Newswire (US)Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform DevelopmentNASDAQ:CELZCreative Medical Technology Holdings Inc
18/05/202314:00PR Newswire (US)Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell LineNASDAQ:CELZCreative Medical Technology Holdings Inc
12/05/202322:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CELZCreative Medical Technology Holdings Inc
01/05/202322:47Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CELZCreative Medical Technology Holdings Inc
12/04/202321:30AllPennyStocks.comBiotech Up Massively On Follow-Up DataNASDAQ:CELZCreative Medical Technology Holdings Inc
12/04/202314:00PR Newswire (US)Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes StudyNASDAQ:CELZCreative Medical Technology Holdings Inc
04/04/202314:00PR Newswire (US)Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
31/03/202322:47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
23/03/202313:00PR Newswire (US)Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 DiabetesNASDAQ:CELZCreative Medical Technology Holdings Inc
21/03/202313:00PR Newswire (US)Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform DevelopmentNASDAQ:CELZCreative Medical Technology Holdings Inc
07/03/202314:00Business WireCreative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201NASDAQ:CELZCreative Medical Technology Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CELZ

La tua Cronologia

BIT
MONC
Moncler
BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
PRY
Prysmian
BIT
SPM
Saipem
BIT
CPR
Davide Campari
BIT
BC
Brunello Cucinelli
BIT
TEN
Tenaris
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network